New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
07:51 EDTPRGOPerrigo receives FDA final approval for generic equivalent to Prandin
Perrigo announced that it has received final approval from the FDA for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
News For PRGO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent PRGO news | >>
April 9, 2015
08:10 EDTPRGOLeerink sees 70% chance of Mylan buying Perrigo with raised bid
Subscribe for More Information
06:20 EDTPRGOTeva bid for Mylan possible, but challenging, says Citigroup
Subscribe for More Information
06:15 EDTPRGOCiti does not see much strategic sense in Mylan, Perrigo deal
Subscribe for More Information
06:02 EDTPRGOPerrigo downgraded to Market Perform from Outperform at William Blair
William Blair downgraded Perrigo (PRGO) to Market Perform after the stock rallied 18% yesterday on Mylan's (MYL) proposal to buy the company for $205 per share.
April 8, 2015
16:22 EDTPRGOOn The Fly: Closing Wrap
Subscribe for More Information
15:27 EDTPRGOMylan hasn't made compelling case for Perrigo adding value, says BMO Capital
Subscribe for More Information
15:16 EDTPRGOPerrigo not likely interested in a Mylan deal, says BMO Capital
14:23 EDTPRGOAdditional bidders for Perrigo could emerge after Mylan offer, says Stifel
Subscribe for More Information
13:07 EDTPRGOMylan bid for Perrigo makes strategic sense, says JPMorgan
Subscribe for More Information
13:03 EDTPRGOPerrigo says board will meet to discuss Mylan proposal
Subscribe for More Information
12:17 EDTPRGOOn The Fly: Midday Wrap
Subscribe for More Information
11:51 EDTPRGOPerrigo calls active on Mylan proposal to acquire for $205 per share
Subscribe for More Information
11:45 EDTPRGOMylan volatility up after proposes to acquire Perrigo for $205 per share
Subscribe for More Information
11:40 EDTPRGOPerrigo up $47.10 to $211.81, trading above Mylan's $205/share proposal
Subscribe for More Information
11:35 EDTPRGOGeneric drug maker Akorn up 4% to $49.80 after Myla offers to buy Perrigo
Subscribe for More Information
11:34 EDTPRGOGeneric drug maker Akorn up 4% to $49.80 after Myla offers to buy Perrigo
11:32 EDTPRGOMylan proposes to acquire Perrigo for $205 per share
Subscribe for More Information
11:31 EDTPRGOPerrigo halted for volatility after jumping 7% to $176.42
Subscribe for More Information
11:29 EDTPRGOMylan proposes to acquire Perrigo for $205 per share
Subscribe for More Information
08:56 EDTPRGOPerrigo's ANDA for equivalent of Mallinckrodt's Exalgo approved by FDA
Subscribe for More Information
1 | 2 | 3 | all recent PRGO news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use